Navigation Links
The Court Supports Bavarian Nordic's Decision to Start Patent Infringement Case Against Oxford BioMedica
Date:5/9/2009

KVISTGARD, Denmark, May 9 /PRNewswire-FirstCall/ -- Oxford Biomedica's second attempt to dismiss Bavarian Nordic's patent infringement suit in the United States has failed. Instead of denying infringement, Oxford Biomedica made yet another attempt to dismiss the suit arguing that it was premature because TroVax(R) was still evaluated in clinical trials. The court ruled against Oxford Biomedica and the case will thus continue, based on the substance of the patents.

Bavarian Nordic owns several United States patents relating to an attenuated strain of the company's core technology, MVA-BN(R), which is the basis for its smallpox vaccine, IMVAMUNE(R). MVA-BN(R) also holds promise as a vector for delivering recombinant vaccines. Bavarian Nordic has asserted four US patents as a basis for its infringement action. The claim in this case is that Oxford BioMedica has infringed Bavarian Nordic's patents by commercializing the patented technology in ways that have yielded large payments from Sanofi-Aventis under the agreement between them for the development and commercialization of TroVax(R).

Anders Hedegaard President and CEO of Bavarian Nordic: "We are pleased with the decision in the court case allowing Bavarian Nordic to continue to defend its valuable intellectual property related to the MVA-BN(R) technology. We will continue vigorously to defend our patents against any infringement that threatens Bavarian Nordic's full commercialization of its intellectual property".

Forward-looking statements

This announcement includes "forward-looking statements" that involve risks, uncertainties and other factors, many of which are outside of our control that could cause actual results to differ materially from the results discussed in the forward-looking statements. Forward-looking statements include statements concerning our plans, objectives, goals, future events, performance and/or other in
'/>"/>

SOURCE Bavarian Nordic A/S
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Hearing Scheduled in the Delaware Court of Chancery for August 27, 2007 to Establish the Valid Approval and Consummation of the Merger Between PharmAthene, Inc. and Healthcare Acquisition Corp.
2. Proceedings to Affirm Merger Between PharmAthene and Healthcare Acquisition Corp Initiated in Delaware Chancery Court
3. Forest Laboratories Announces Federal Appeals Court Upholds Lexapro(R) Patent Decision
4. Agencourt Genomic Services is Key Collaborator in New Research That Further Defines Landscape of Breast and Colon Cancers
5. U.S. District Court Decision About Eisais Legal Action Over Aricept ODT(R) ANDA Filing
6. Delaware Court Denies Motion by SIGA Technologies Seeking to Dismiss PharmAthenes Legal Action in Breach of Contract Lawsuit Against SIGA
7. AstraZeneca Response to February 21, 2008 Ruling In Re: Alabama Medicaid Pharmaceutical AWP Litigation - cv2005-219 - Circuit Court of Montgomery, Alabama
8. Results of Court Meeting and Extraordinary General Meeting - Shareholders Approve Scheme of Arrangement and New Share Plans
9. Retired Supreme Court Justice Sandra Day OConnor and Former House Speaker Newt Gingrich Address Senate Special Committee on Aging, Calling for Urgent Action Against Alzheimers Disease
10. Court Determines that University of Pittsburgh and Artecel Have Sole Rights to Adipose-Derived Stem Cell Patent
11. Concerned Shareholders of Biovail seek court order declaring Biovail AGM illegally convened;

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)... . , Whether it,s CD packaging, containers o... Identification) are increasingly finding their wa...el objects or goods and identify them automaticall...read and process the data contained in the label. ...ion conditions of up to 100 degrees Celsius. But a...
(Date:11/24/2009)...investment bank KTA Capital,s client Neuren Pharma...onvertible note private placement with a U.S. inst...nged by KTA Capital as Neuren,s exclusive placemen...w York (PRWEB) November 23, 2009 -- The independen...;KTA Capital") has announced that its client ...
(Date:11/24/2009)... Iceland, November 24 de...d that it has received notice from,the Nasdaq Stoc...k will be,suspended as of November 30, 2009 and a ...Exchange Commission, which will remove deCODE,s co...any files an appeal to the Nasdaq,Listing Qualific...
(Date:11/24/2009)... Iceland, November 24 de...d the approval of all of its,"first day" motions b...laware,(the "Bankruptcy Court"). deCODE last week ...r 11 of the United States Bankruptcy Code with the... the Bankruptcy Court allow the company to continu...
Breaking Biology Technology:Intelligence inside metal components 2KTA Capital Arranges an AU$6.7 Million Private Placement by Neuren Pharmaceuticals 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 3deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 3
...uXi PharmaTech (NYSE:,WX), China,s premier provide...nced today that it has been ranked the 28th in the...ing of the 50 fastest growing technology,companies...Marriott Hotel,Shanghai at Tomorrow Square, Shangh...cgi-bin/prnh/20040705/CNM002LOGO ) The Deloitte ...
...New York on November 5th, SAN DIEGO, Oct. 26 Fav...mpany developing patient-specific, active,immunoth...ed that the,Company will present at three upcoming....com/cgi-bin/prnh/20031013/LAM095LOGO ), -- Richa...nt at the BIOCOM Investor Conference at 11:00 ...
...AL), a life science company dedicated to providing...cts to the world,s researchers, and Oxford,BioMedi...ounced today that,they received a key order confir...perty owned by Oxford BioMedica and licensed exclu... ruling was part of the,construction of patent cla...
Other Biology Technology:WuXi PharmaTech (NYSE: WX) Ranked the 28th of Deloitte Technology Fast 50 China 2Favrille to Present at BIOCOM Investor Conference, Acumen BioFin Rodman & Renshaw Healthcare Conference and CIBC World Markets Healthcare Conference 2Sigma-Aldrich and Oxford BioMedica Win Key Ruling in Open Biosystems Patent Infringement Dispute 2Sigma-Aldrich and Oxford BioMedica Win Key Ruling in Open Biosystems Patent Infringement Dispute 3
(Date:11/26/2009)...taphylococcus Aureus ) and other drug-resistant ba...plasma prototype devices have been developed to of...ocktails. , Two prototype devices have been deve...kin (e.g. hands and feet) in hospitals and public ...d another to shoot bacteria-killing agents into in...
(Date:11/25/2009)...ve easy lives. In addition to mammalian immune sys...ies called bacteriophages, viruses that kill half ...bacteria and another class of microorganisms calle...s such as deep-sea volcanic vents) manage just fin... defense system that helps protect them from many ...
(Date:11/25/2009)... Soil is the linchpin of the environment, where a...e that, many students see soil as "just dirt" a p...e educators are challenged with the task of helpin...mportance of soil in the environment. , A colla... teachers at University of Nebraska-Lincoln, Orego...
Breaking Biology News(10 mins):Plasma produces KO cocktail for MRSA 2Plasma produces KO cocktail for MRSA 3Researchers discover biological basis of 'bacterial immune system' 2Researchers discover biological basis of 'bacterial immune system' 3It's not just dirt! 2Surprise 21 Jamba Juice Treats Lucky San Francisco Cable Car Passengers to Free Rides on Saturday October 17 59621 1Surprise 21 Jamba Juice Treats Lucky San Francisco Cable Car Passengers to Free Rides on Saturday October 17 59621 2Surprise 21 Jamba Juice Treats Lucky San Francisco Cable Car Passengers to Free Rides on Saturday October 17 59621 3Houston Plastic Surgeon Seeing Growth in Aesthetic Enhancement Procedures Despite Rough Economy 59620 1Houston Plastic Surgeon Seeing Growth in Aesthetic Enhancement Procedures Despite Rough Economy 59620 2Houston Plastic Surgeon Seeing Growth in Aesthetic Enhancement Procedures Despite Rough Economy 59620 3Swanson Health Products Joins Peggy Fleming in Promoting the Heart Health Benefits of Ubiquinol a CoQ10 Dietary Supplement 59616 1Swanson Health Products Joins Peggy Fleming in Promoting the Heart Health Benefits of Ubiquinol a CoQ10 Dietary Supplement 59616 2Swanson Health Products Joins Peggy Fleming in Promoting the Heart Health Benefits of Ubiquinol a CoQ10 Dietary Supplement 59616 3
...ot a source of carbon dioxide to the atmosphere, a...er 25) in the journal Science. The study was carri...m UC Davis, the Catholic University of Leuven in B... Carbon emissions are of great concern worldwide ...t in the Earth,s atmosphere and are a major cause ...
... a transporter of cholesterol, may also contribute... mechanism, according to a report published online...nk between native LDL (nLDL) and the vascular endo...lays a central role in blood vessel formation. , ...om the liver to peripheral tissues. During transit...
...e University was awarded a three-year grant from t...cultural and economic impacts of the "biofuels rev...The $696,827 grant comes from the department,s Eth...on Alternative Bioenergy Technologies, Synthetic G...s from K-State,s department of sociology, anthropo...
Other Biology News:Agricultural soil erosion is not adding to global warming 2K-State sociologists use Department of Energy grant 2
Wash Solution from CHEMICON
Agarose, high EEO, Molecular Biology Grade from Research Organics, Inc.
Donor Bovine Serum - 500mL from Biomeda Corporation
Rabbit Anti-Human Q86TS7 Polyclonal Antibody, Unconjugated from Atlas Antibodies
Biology Products: